FILE PHOTO: A sign marks the headquarters of Moderna Therapeutics, which is developing a vaccine against coronavirus (COVID-19), in Cambridge, Massachusetts, USA, May 18, 2020. REUTERS / Brian Snyder (Reuters) – Drug Developer Moderna Inc (MRNA.O) on Friday said it has so far enrolled 13,194 participants in the ongoing 30,000-volunteer …
Read More »
(Reuters) – The following is a roundup of some of the latest scientific studies on the new coronavirus and efforts to find treatments and vaccines for COVID-19, the disease caused by the virus. New questions about inhibitor COVID-19 efficacy A new study raises fresh questions about the effectiveness of Gilead …
Read More »
(Reuters) – The U.S. Food and Drug Administration was able to update its emergency use authorization for Gilead Sciences Inc’s (GILD.O) brakesivir of drugs to admit patients admitted to hospital with moderate COVID-19, despite mixed test results, the company’s top study said on Friday. FILE PHOTO: An ampoule of Ebola …
Read More »
CHICAGO / NEW YORK (Reuters) – Approximately one-fifth of the 11,000 people enrolled in a 30,000-volunteer U.S. trial of a Pfizer COVID-19 vaccine (PFE.N) and German partner BioNTech (22UAy.F) are Black as Latino, groups among the hardest hit by the coronavirus virus pandemic, said a top Pfizer executive. PHILO PHOTO: …
Read More »
House Speaker Nancy Pelosi (D-CA) speaks through video format during the Virtual Democratic National Convention as nationwide participants host video clips from the convention’s originally scheduled site in Milwaukee, Wisconsin, US August 19, 2020 2020 Democratic National Convention / Pool via REUTERS WASHINGTON (Reuters) – Speaker Nancy Pelosi, the U.S. …
Read More »